Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

By: News Direct

March 09, 2023 at 07:53 AM EST

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498

More News

As Digital Ad Spend Hits a High, These Firms Could Reap Rewards ↗

Today 11:50 EDT

Via MarketBeat

Upstart Surges on Record Revenue but Wall Street Remains Divided ↗

Today 11:14 EDT

Via MarketBeat

HP Inc. Stock Is Historically Cheap, but Can AI Change the Story? ↗

Today 10:44 EDT

Via MarketBeat

This Expensive Chip Stock Is Up 140%, Analysts Say It's Still a Buy ↗

Today 10:03 EDT

Via MarketBeat

AirJoule on Commercialization Path: Sales Will Start Soon ↗

Today 9:27 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	212.81	+4.53 (2.18%)
AAPL	254.13	+0.34 (0.13%)
AMD	212.46	+9.03 (4.44%)
BAC	49.37	+0.62 (1.27%)
GOOG	295.23	+8.37 (2.92%)
META	583.38	+11.25 (1.97%)
MSFT	372.20	+2.03 (0.55%)
NVDA	176.94	+2.53 (1.45%)
ORCL	146.44	-0.67 (-0.46%)
TSLA	381.60	+9.85 (2.65%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.